Steven H. Collis, Director at Elevance Health, Inc. (ELV), bought 3,000 shares at $289.84 ($870K) on 2026-03-05, disclosed to the SEC on 2026-03-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| COR | SELL | 2025-08-20 | $8.5M | — | Filing → |
| COR | SELL | 2025-07-23 | $8.5M | — | Filing → |
| COR | SELL | 2025-06-25 | $8.5M | — | Filing → |